|
|
|
Scientific Literature, breast cancer
-
Abba MC, Hu Y, Levy CC, Gaddis S, Kittrell FS, Zhang Y, Hill J, Bissonnette RP, Medina D, Brown PH, Aldaz CM 2008 Transcriptomic signature of the chemopreventive bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.
BMC Med. Genomics 1: 40.
*
-
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J 2008 Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.
Breast Cancer Res. 10: R31.
*
-
Abedin SA, Banwell CM, Colston KW, Carlberg C, Campbell MJ 2006 Epigenetic corruption of VDR signalling in malignancy.
Anticancer Res. 26: 2557-2566.
-
Aboody KS, Najbauer J, Danks MK 2008 Stem and progenitor cell-mediated tumor selective gene therapy.
Gene Ther. 15: 739-752.
-
Adair SJ, Carr TM, Fink MJ, Slingluff CL Jr, Hogan KT 2008 The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
J. Immunother. 31: 7-17.
-
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA 2008 Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
Prostate 68: 740-747.
-
Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB 2006 Anticancer potential of silymarin: from bench to bed side.
Anticancer Res. 26: 4457-4498.
-
Aggarwal BB, Sethi G, Nair A, Ichikawa H 2006 Nuclear factor-kB: a holy grail in cancer prevention and therapy.
Current Signal Transduction Therapy 1: 25-52. *
-
Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, Salazar L, Molina MC, Guerrero J, Lopez M, Soto L, Salazar-Onfray F, Cuchacovich M 2003 New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies.
Rev. Med. Chil. 131: 1445-1453.
-
Agundez JA 2008 Polymorphisms of human N-acetyltransferases and cancer risk.
Curr. Drug Metab. 9: 520-531.
-
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB 2006 Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk.
Carcinogenesis 27: 1876-1882.
*
-
Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB 2008 Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway.
Int. J. Cancer 123: 1733-1740.
*
-
Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J 2005 Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Biochem. Pharmacol. 70: 949-958.
*
-
Albrecht C, Elliott JI, Sardini A, Litman T, Stieger B, Meier PJ, Higgins CF 2002 Functional analysis of candidate ABC transporter proteins for sitosterol transport.
Biochim. Biophys. Acta 1567: 133-142.
*
-
Ali MF, Meza JL, Rogan EG, Chakravarti D 2008 Prevalence of BER gene polymorphisms in sporadic breast cancer.
Oncol. Rep. 19: 1033-1038.
-
Ali MM, Vaidya V 2007 Vitamin D and cancer.
J. Cancer Res. Ther. 3: 225-230.
*
-
Allen JD, Van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH 2003 Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Cancer Res. 63: 1339-1344.
*
-
Alonso A, Hernan MA, Ascherio A 2008 Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis.
Acta Neurol. Scand. 117: 15-20.
*
-
Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E 2006 Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
Am. J. Pathol. 169: 877-888.
*
-
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB 2008 Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Cancer Lett. 267: 133-164.
*
-
Anderson JE, Hansen LL, Mooren FC, Post M, Hug H, Zuse A, Los M 2006 Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Drug Resist. Updat. 9: 198-210.
-
Anderson LA, McMillan SA, Watson RG, Monaghan P, Gavin AT, Fox C, Murray LJ 2007 Malignancy and mortality in a population-based cohort of patients with coeliac disease or 'gluten sensitivity'.
World J. Gastroenterol. 13: 146-151.
*
-
Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, Engelman DM, Reshetnyak YK 2007 Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.
Proc. Natl. Acad. Sci. U.S.A. 104: 7893-7898.
*
-
Angelo LS, Kurzrock R 2007 Vascular endothelial growth factor and its relationship to inflammatory mediators.
Clin. Cancer Res. 13: 2825-2830.
*
-
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, Zitvogel L 2007 The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
Immunol. Rev. 220: 47-59.
*
-
Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM 2001 Hepatitis B vaccination and the risk of multiple sclerosis.
N. Engl. J. Med. 344: 327-332.
*
-
Assaraf YG 2006 The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Drug Resist. Updat. 9: 227-246.
-
Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G 2003 Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells.
J. Biol. Chem. 278: 6680-6686.
*
-
Atalay C, Atalay G, Yilmaz KB, Altinok M 2005 The role of anti-CENP-B and anti-SS-B antibodies in breast cancer.
Neoplasma 52: 32-35.
*
-
Atalay C, Deliloglu Gurhan I, Irkkan C, Gunduz U 2006 Multidrug resistance in locally advanced breast cancer.
Tumour Biol. 27: 309-318.
-
Aung CS, Faddy HM, Lister EJ, Monteith GR, Roberts-Thomson SJ 2006 Isoform specific changes in PPARalpha and beta in colon and breast cancer with differentiation.
Biochem. Biophys. Res. Commun. 340: 656-660.
*
-
Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW 2004 Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.
Breast Cancer Res. 6: R395-R400.
*
-
Badawi AF, Badr MZ 2002 Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma.
Int. J. Oncol. 20: 1109-1122.
-
Bailey LB 2003 Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations.
J. Nutr. 133: 3748S-3753S.
*
-
Bailey-Dell KJ, Hassel B, Doyle LA, Ross DD 2001 Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
Biochim. Biophys. Acta 1520: 234-241.
*
-
Ban Y, Taniyama M, Tozaki T, Tomita M, Ban Y 2000 Estrogen receptor alpha dinucleotide repeat polymorphism in Japanese patients with autoimmune thyroid diseases.
BMC Med. Genet. 1: 1.
*
-
Banwell CM, Maccartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O'neill LP, Turner BM, Colston KW, Campbell MJ 2006 Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Clin. Cancer Res. 12: 2004-2013.
*
-
Barton JC, Bertoli LF, Acton RT 2004 HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.
BMC Cancer 4: 6.
*
-
Barutca S, Kadikoylu G, Meydan N, Bolaman Z, Gokcen A, Bal F 2003 Two autoimmune diseases: Hashimoto's thyroiditis and vitiligo accompanying breast cancer; a coincidence?
J. BUON 8: 177-179.
-
Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W 2007 Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.
J. Soc. Integr. Oncol. 5: 92-105.
-
Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ 2005 Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Mol. Carcinog. 44: 151-161.
*
-
Batrakova EV, Kelly DL, Li S, Li Y, Yang Z, Xiao L, Alakhova DY, Sherman S, Alakhov VY, Kabanov AV 2006 Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
Mol. Pharm. 3: 113-123.
*
-
Becker P, Maurer B, Schirmacher P, Waldherr R, Parlesak A, Bode C, Seitz HK 2007 Vitamin A-induced cholestatic hepatitis: a case report.
Z. Gastroenterol. 45: 1063-1066.
-
Bensing S, Brandt L, Tabaroj F, Sjoberg O, Nilsson B, Ekbom A, Blomqvist P, Kampe O 2008 Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Clin. Endocrinol. (Oxf.) Aug 22 [Epub ahead of print].
*
-
Berdowska I 2004 Cysteine proteases as disease markers.
Clin. Chim. Acta 342: 41-69.
*
-
Bergasa NV 1998 Primary biliary cirrhosis in patients with breast cancer: studying the link.
Med. Hypotheses 50: 465-472.
-
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group.
Hepatology 40: 1013-1020.
*
-
Bernstein CN 1998 Challenges in designing a randomized trial of surveillance colonoscopy in IBD.
Inflamm. Bowel Dis. 4: 132-141.
*
-
Berquin IM, Edwards IJ, Chen YQ 2008 Multi-targeted therapy of cancer by omega-3 fatty acids.
Cancer Lett. May 12 [Epub ahead of print].
*
-
Bettoun DJ, Burris TP, Houck KA, Buck DW 2nd, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S 2003 Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Mol. Endocrinol. 17: 2320-2328.
*
-
Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J, Benz CC 2008 Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells.
Oncogene May 26 [Epub ahead of print].
*
-
Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benezzato L, Papi C, Meucci G, Riegler G, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F 2006 Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched-pair study.
Gut 55: 228-233.
*
-
Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, et al 2001 Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Ann. Rheum. Dis. 60: 577-584.
*
-
Blaber SI, Yoon H, Scarisbrick IA, Juliano MA, Blaber M 2007 The autolytic regulation of human kallikrein-related peptidase 6.
Biochemistry 46: 5209-5217.
*
-
Bocca C, Bozzo F, Francica S, Colombatto S, Miglietta A 2007 Involvement of PPARgamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells.
Int. J. Cancer 121: 248-256.
*
-
Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A 2008 Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Br. J. Nutr. 100: 739-750.
*
-
Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Ando S 2005 Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Clin. Cancer Res. 11: 6139-6147.
*
-
Bosnjak AP, Grguric J 2007 Long-term health effects of breastfeeding.
Lijec. Vjesn. 129: 293-298.
-
Bougnoux P, Giraudeau B, Couet C 2006 Diet, cancer, and the lipidome.
Cancer Epidemiol. Biomarkers Prev. 15: 416-421.
*
-
Bourre JM 2007 Dietary omega-3 fatty acids for women.
Biomed. Pharmacother. 61: 105-112.
-
Brayman MJ, Dharmaraj N, Lagow E, Carson DD 2007 MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Mol. Endocrinol. 21: 2725-2737.
*
-
Brinton LA, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC, Hoover R 2004 Risk of connective tissue disorders among breast implant patients.
Am. J. Epidemiol. 160: 619-627.
*
-
Brooks TA, Kennedy DR, Gruol DJ, Ojima I, Baer MR, Bernacki RJ 2004 Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.
Anticancer Res. 24: 409-415.
-
Brown SL 2002 Epidemiology of silicone-gel breast implants.
Epidemiology 13: S34-S39.
-
Brtko J 2007 Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention.
Cent. Eur. J. Public Health 15: 3-6.
-
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM 2006 An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Breast Cancer Res. Treat. 99: 257-265.
*
-
Buc E, Lesurtel M, Belghiti J 2008 Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?
HPB (Oxford) 10: 98-105.
*
-
Buell JF, Woodle ES 2004 Syndromic incidence of ovarian cancer after liver transplantation: is breast cancer an antecedent risk?
Liver Transpl. 10: 156-157.
*
-
Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E 2004 Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls.
AIDS Res. Hum. Retroviruses 20: 1223-1229.
-
Byrne B, Welsh J 2007 Identification of novel mediators of vitamin D signaling and 1,25(OH)(2)D(3) resistance in mammary cells.
J. Steroid Biochem. Mol. Biol. 103: 703-707.
-
Calzascia T, Pellegrini M, Hall H, Sabbagh L, Ono N, Elford AR, Mak TW, Ohashi PS 2007 TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.
J. Clin. Invest. 117: 3833-3845.
*
-
Calzascia T, Pellegrini M, Lin A, Garza KM, Elford AR, Shahinian A, Ohashi PS, Mak TW 2008 CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.
Proc. Natl. Acad. Sci. U.S.A. 105: 2999-3004.
*
-
Caramia G 2008 Omega-3: from cod-liver oil to nutrigenomics.
Minerva. Pediatr. 60: 443-455.
-
Caygill CP, Charlett A, Hill MJ 1996 Fat, fish, fish oil and cancer.
Br. J. Cancer 74: 159-164.
-
Caygill CP, Hill MJ 1995 Fish, n-3 fatty acids and human colorectal and breast cancer mortality.
Eur. J. Cancer Prev. 4: 329-332.
-
Chabas D 2005 Osteopontin, a multi-faceted molecule.
Med. Sci. (Paris) 21: 832-838.
-
Chandra P, Brouwer KL 2004 The complexities of hepatic drug transport: current knowledge and emerging concepts.
Pharm. Res. 21: 719-735.
*
-
Chang XB 2007 A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1.
Cancer Metastasis Rev. 26: 15-37.
*
-
Chaturvedi P, Singh AP, Batra SK 2008 Structure, evolution, and biology of the MUC4 mucin.
FASEB J. 22: 966-981.
*
-
Chen M, Crowson AN, Woofter M, Luca MB, Magro CM 2004 Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases.
J. Rheumatol. 31: 818-820.
-
Chen NJ, Chio II, Lin WJ, Duncan G, Chau H, Katz D, Huang HL, Pike KA, Hao Z, Su YW, Yamamoto K, de Pooter RF, Zuniga-Pflucker JC, Wakeham A, Yeh WC, Mak TW 2008 Beyond tumor necrosis factor receptor: TRADD signaling in Toll-like receptors.
Proc. Natl. Acad. Sci. U.S.A. 105: 12429-12434.
*
-
Chen X, Guan J, Song Y, Chen P, Zheng H, Tang C, Wu Q 2008 IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis.
J. Hum. Genet. 53: 227-238.
*
-
Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M, Marshall GM 2003 Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.
Int. J. Cancer 105: 856-867.
*
-
Chlon TM, Taffany DA, Welsh J, Rowling MJ 2008 Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells.
J. Nutr. 138: 1323-1328.
-
Cho JH 2001 Update on the genetics of inflammatory bowel disease.
Curr. Gastroenterol. Rep. 3: 458-463.
-
Cho YG, Choi BJ, Kim CJ, Song JH, Zhang C, Nam SW, Lee JY, Park WS 2008 Genetic analysis of the DBC2 gene in gastric cancer.
Acta Oncol. 47: 366-371.
-
Choi HK, Yang JW, Roh SH, Han CY, Kang KW 2007 Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
Endocr. Relat. Cancer 14: 293-303.
-
Choubey D, Deka R, Ho SM 2008 Interferon-inducible IFI16 protein in human cancers and autoimmune diseases.
Front. Biosci. 13: 598-608.
-
Christakos S, Dhawan P, Shen Q, Peng X, Benn B, Zhong Y 2006 New insights into the mechanisms involved in the pleiotropic actions of 1,25dihydroxyvitamin D3.
Ann. N. Y. Acad. Sci. 1068: 194-203.
-
Chun KS, Surh YJ 2004 Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
Biochem. Pharmacol. 68: 1089-1100.
*
-
Chuu CP, Kokontis JM, Hiipakka RA, Liao S 2007 Modulation of liver X receptor signaling as novel therapy for prostate cancer.
J. Biomed. Sci. 14: 543-553.
*
-
Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zajac V 2006 Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Neoplasma 53: 97-102.
*
-
Clarke N, Germain P, Altucci L, Gronemeyer H 2004 Retinoids: potential in cancer prevention and therapy.
Expert Rev. Mol. Med. 6: 1-23.
-
Clayton A, Ramamurthy S 2008 The impact of physical illness on sexual dysfunction.
Adv. Psychosom. Med. 29: 70-88.
-
Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS 2004 Autoimmune hepatitis associated with the use of black cohosh: a case study.
Menopause 11: 575-577.
-
Coles BF, Kadlubar FF 2005 Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease.
Methods Enzymol. 401: 9-42.
-
Combes B, Luketic VA, Peters MG, Zetterman RK, Garcia-Tsao G, Munoz SJ, Lin D, Flye N, Carithers RL Jr 2004 Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
Am. J. Gastroenterol. 99: 264-268.
*
-
Conde I, Lobo MV, Zamora J, Perez J, Gonzalez FJ, Alba E, Fraile B, Paniagua R, Arenas MI 2008 Human pregnane X receptor is expressed in human breast carcinomas, potential heterodimer formation between hPXR and RXR-alpha.
BMC Cancer 8: 174.
*
-
Conde I, Paniagua R, Fraile B, Ruiz A, Arenas MI 2004 Expression of vitamin D3 receptor and retinoid receptors in human breast cancer: identification of potential heterodimeric receptors.
Int. J. Oncol. 25: 1183-1191.
-
Conney AH 2004 Tailoring cancer chemoprevention regimens to the individual.
J. Cell. Biochem. 91: 277-286.
*
-
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA 2004 Interaction of the breast cancer resistance protein with plant polyphenols.
Biochem. Biophys. Res. Commun. 317: 269-275.
*
-
Corder EH, Hefler LA 2006 Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma.
Rejuvenation Res. 9: 56-60.
-
Cordes T, Diesing D, Becker S, Diedrich K, Reichrath J, Friedrich M 2006 Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
Anticancer Res. 26: 2749-2753.
-
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F 2007 DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population.
Breast Cancer Res. Treat. 103: 209-217.
*
-
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F 2008 Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
BMC Cancer 8: 32.
*
-
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB et al 2007 AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Cancer Epidemiol. Biomarkers Prev. 16: 1416-1421.
-
Cox DG, Buring J, Hankinson SE, Hunter DJ 2007 A polymorphism in the 3' UTR of PTGS2 is not associated with an increase in breast cancer risk: a nested case-control study.
Breast Cancer Res. 9: R3.
*
-
Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, Hunter KW 2007 Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.
PLoS Genet. 3: e214.
*
-
Crivellari D, Cannizzaro R, Galligioni E, Valentini M, Monfardini S, Castiglione M 1992 Adjuvant therapy for primary breast cancer in a female patient affected by autoimmune liver disease: does it cure breast cancer and primary biliary cirrhosis?
Tumori. 78: 395-396.
-
Crowe DL, Chandraratna RA 2004 A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Breast Cancer Res. 6: R546-R555.
*
-
Csaszar A, Abel T 2001 Receptor polymorphisms and diseases.
Eur. J. Pharmacol. 414: 9-22.
*
-
Cui Y, Lu Z, Bai L, Shi Z, Zhao WE, Zhao B 2007 beta-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells.
Eur. J. Cancer 43: 2590-2601.
*
-
Cui Y, Rohan TE 2006 Vitamin D, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev. 15: 1427-1437.
*
-
Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, Demichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ 2007 Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.
Cancer Res. 67: 1842-1852.
*
-
da Silva Correia J, Miranda Y, Austin-Brown N, Hsu J, Mathison J, Xiang R, Zhou H, Li Q, Han J, Ulevitch RJ 2006 Nod1-dependent control of tumor growth.
Proc. Natl. Acad. Sci. U.S.A. 103: 1840-1845.
*
-
Dagan E, Laitman Y, Levanon N, Feuer A, Sidi AA, Baniel J, Korach Y, Baruch GB, Friedman E, Gershoni-Baruch R 2006 The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.
Fam. Cancer 5: 389-395.
*
-
Dairkee SH, Ji Y, Ben Y, Moore DH, Meng Z, Jeffrey SS 2004 A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.
BMC Genomics 5: 47.
*
-
Dalhoff K, Buus Jensen K, Enghusen Poulsen H 2005 Cancer and molecular biomarkers of phase 2.
Methods Enzymol. 400: 618-627.
-
Dalmeijer GW, Olthof MR, Verhoef P, Bots ML, van der Schouw YT 2008 Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women.
Eur. J. Clin. Nutr. 62: 386-394.
*
-
Daly AK 2006 Significance of the minor cytochrome P450 3A isoforms.
Clin. Pharmacokinet. 45: 13-31.
-
Dang CT, Shapiro CL, Hudis CA 2002 Potential role of selective COX-2 inhibitors in cancer management.
Oncology (Huntingt.) 16: 30-36.
-
Das S, Nwachukwu JC, Li D, Vulin AI, Martinez-Caballero S, Kinnally KW, Samuels HH 2007 The nuclear receptor interacting factor-3 transcriptional coregulator mediates rapid apoptosis in breast cancer cells through direct and bystander-mediated events.
Cancer Res. 67: 1775-1782.
*
-
Das UN 2004 Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases.
Med. Sci. Monit. 10: HY19-HY25.
*
-
de Deckere EA 1999 Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer.
Eur. J. Cancer Prev. 8: 213-221.
-
de Jong MM, Niens M, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G, Bruinenberg M, Schaapveld M, Sijmons RH, Hofstra RM, de Vries EG, Kleibeuker JH 2005 The human leukocyte antigen region and colorectal cancer risk.
Dis. Colon Rectum 48: 303-306.
*
-
de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Goes JC, Folgueira MA 2006 25(OH)D(3) and 1,25(OH)(2)D(3) serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
J. Steroid Biochem. Mol. Biol. 100: 184-192.
-
Decensi A, Costa A 2000 Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.
Eur. J. Cancer 36: 694-709.
*
-
Deeken JF, Figg WD, Bates SE, Sparreboom A 2007 Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Anticancer Drugs 18: 111-126.
-
Degerli N, Yilmaz E, Bardakci F 2005 The Delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population.
Clin. Biochem. 38: 248-252.
*
-
Desai PB, Nallani SC, Sane RS, Moore LB, Goodwin BJ, Buckley DJ, Buckley AR 2002 Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.
Drug Metab. Dispos. 30: 608-612.
*
-
Desmetz C, Bibeau F, Boissiere F, Bellet V, Rouanet P, Maudelonde T, Mange A, Solassol J 2008 Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.
J. Proteome Res. 7: 3830-3837.
*
-
Dhillon NK, Mudryj M 2003 Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells.
Genes Immun. 4: 336-342.
*
-
Diesing D, Cordes T, Fischer D, Diedrich K, Friedrich M 2006 Vitamin D - metabolism in the human breast cancer cell line MCF-7.
Anticancer Res. 26: 2755-2759.
-
Dietrich CG, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink RP, Matern S, Gartung C 2004 Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2.
Gastroenterology 126: 1044-1053.
*
-
Dietrich CG, Geier A, Wasmuth HE, Matern S, Gartung C, de Waart DR, Elferink RP 2004 Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen.
Gut 53: 1850-1855.
*
-
Dimberg J, Hugander A, Lofgren S, Wagsater D 2007 Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
Int. J. Mol. Med. 19: 11-15.
*
-
Disanti W, Rajapakse RO, Korelitz BI, Panagopoulos G, Bratcher J 2006 Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
Clin. Gastroenterol. Hepatol. 4: 1025-1029.
-
Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R 2006 Diet and cancer.
Acta Biomed. Ateneo. Parmense. 77: 118-123.
-
Donaldson MS 2004 Nutrition and cancer: a review of the evidence for an anti-cancer diet.
Nutr. J. 3: 19.
*
-
Doyle LA, Ross DD 2003 Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Oncogene 22: 7340-7358.
*
-
Dufner A, Pownall S, Mak TW 2006 Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-KB activation.
Proc. Natl. Acad. Sci. U.S.A. 103: 988-993.
*
-
Duncan RE, Archer MC 2006 Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells.
Biochem. Biophys. Res. Commun. 343: 239-243.
*
-
Duncan RE, El-Sohemy A, Archer MC 2005 Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin.
Cancer Lett. 224: 221-228.
*
-
Dunham A, Matthews LH, Burton J, Ashurst JL, Howe KL, Ashcroft KJ, Beare DM et al 2004 The DNA sequence and analysis of human chromosome 13.
Nature 428: 522-528.
*
-
Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C 2005 The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D(3) and its nuclear receptor.
J. Mol. Biol. 349: 248-260.
*
-
Dupuy J, Lespine A, Sutra JF, Alvinerie M 2006 The interaction between moxidectin and MDR transporters in primary cultures of rat hepatocytes.
J. Vet. Pharmacol. Ther. 29: 107-111.
-
Eaden J, Mayberry MK, Sherr A, Mayberry JF 2001 Screening: the legal view.
Public Health 115: 218-221.
-
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, et al 2007 Genome-wide association study identifies novel breast cancer susceptibility loci.
Nature 447: 1087-1093.
-
Ehrmann J Jr, Vavrusova N, Collan Y, Kolar Z 2002 Peroxisome proliferator-activated receptors (PPARs) in health and disease.
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 146: 11-14.
*
-
Ekbom A, Helmick C, Zack M, Adami HO 1991 Extracolonic malignancies in inflammatory bowel disease.
Cancer 67: 2015-2019.
-
El-Bayoumy K, Sinha R 2005 Molecular chemoprevention by selenium: a genomic approach.
Mutat. Res. 591: 224-236.
-
Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT 2007 Masquerader: high mobility group box-1 and cancer.
Clin. Cancer Res. 13: 2836-2848.
*
-
Emens LA, Reilly RT, Jaffee EM 2005 Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity.
Endocr. Relat. Cancer 12: 1-17.
*
-
Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, Clavel-Chapelon F, Thiebaut A, Chajes V, Key TJ, Allen NE, Amiano P, Dorronsoro M, Tjonneland A, Stripp C, Peeters PH, van Gils CH, Chirlaque MD, Nagel G, Linseisen J, Ocke MC, Bueno-de-Mesquita HB, et al 2006 Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC).
Int. J. Cancer 119: 175-182.
*
-
Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, Ronnblom A 2007 Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).
Inflamm. Bowel Dis. 13: 291-297.
*
-
Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH 2006 Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
World J. Gastroenterol. 12: 1536-1544.
*
-
Enokizono J, Kusuhara H, Sugiyama Y 2007 Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect.
Drug Metab. Dispos. 35: 209-214.
*
-
Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, Ghaderi A 2006 Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer.
Cancer Genet. Cytogenet. 165: 114-120.
-
Esteban E, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Vona G, Harich N, Luna F, Saetta AA, Bissar N, Moral P 2005 An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region.
Am. J. Hum. Biol. 17: 690-695.
-
Etkind P, Du J, Khan A, Pillitteri J, Wiernik PH 2000 Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient.
Clin. Cancer Res. 6: 1273-1278.
*
-
Everson GT 2000 Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
Liver Transpl. 6 (6 Suppl. 2): S2-S10.
*
-
Faddy HM, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ 2006 Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate.
Int. J. Biochem. Cell. Biol. 38: 255-266.
*
-
Fazi B, Bursch W, Fimia GM, Nardacci R, Piacentini M, Di Sano F, Piredda L 2008 Fenretinide induces autophagic cell death in caspase-defective breast cancer cells.
Autophagy 4: 435-441.
-
Feld J, Heathcote E 2003 Epidemiology of autoimmune liver disease.
J. Gastroenterol. Hepatol. 18: 1118-1128.
*
-
Fernandez E, Gallus S, La Vecchia C 2006 Nutrition and cancer risk: an overview.
J. Br. Menopause Soc. 12: 139-142.
-
Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E 2005 Genetic analyses in consecutive Israeli Jewish colorectal cancer patients.
Am. J. Gastroenterol. 100: 1376-1380.
*
-
Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E 2001 The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
Br. J. Cancer 84: 478-481.
*
-
Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Naccarato R 1999 Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
Hepatology 29: 1425-1428.
*
-
Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R 1993 Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
Ital. J. Gastroenterol. 25: 473-476.
-
Floreani A, Titta M, Plebani M, Faggian D, Chiaramonte M, Naccarato R 1991 Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease.
Clin. Exp. Obstet. Gynecol. 18: 229-234.
-
Francisco G, Menezes PR, Eluf-Neto J, Chammas R 2008 XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
Eur. J. Hum. Genet. 16: 724-734.
*
-
Franco J, Saeian K 1999 Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Curr. Gastroenterol. Rep. 1: 95-101.
-
Frosk P, Burgess S, Dyck T, Jobse R, Spriggs EL 2007 The use of ancestral haplotypes in the molecular diagnosis of familial breast cancer.
Genet. Test. 11: 208-215.
-
Fu L, Tomita A, Wang H, Buchholz DR, Shi YB 2006 Transcriptional regulation of the Xenopus laevis stromelysin-3 gene by thyroid hormone is mediated by a DNA element in the first intron.
J. Biol. Chem. 281: 16870-16878.
*
-
Fujii S, Ito K, Ito Y, Ochiai A 2008 Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.
J. Biol. Chem. 283: 17324-17332.
*
-
Fujii T, Yokoyama G, Takahashi H, Namoto R, Nakagawa S, Toh U, Kage M, Shirouzu K, Kuwano M 2008 Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer.
Breast Cancer 15: 73-78.
-
Fulton A, Miller F, Weise A, Wei WZ 2007 Prospects of controlling breast cancer metastasis by immune intervention.
Breast Dis. 26: 115-127.
-
Gadi VK, Nelson JL 2007 Fetal microchimerism in women with breast cancer.
Cancer Res. 67: 9035-9038.
*
-
Galhenage SP, Viiala CH, Olynyk JK 2004 Screening for hemochromatosis: patients with liver disease, families, and populations.
Curr. Gastroenterol. Rep. 6: 44-51.
-
Gallagher E, Mc Goldrick A, Chung WY, Mc Cormack O, Harrison M, Kerin M, Dervan PA, Mc Cann A 2006 Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer.
Genomics 88: 12-17.
*
-
Ganti AK, Landmark JD, Kessinger A, Smith LM, Tarantolo SR 2006 Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
In Vivo 20: 559-563.
-
Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, Kladny J, Gronwald J, Gorski B, Cybulski C, Lubinski J, Debniak T 2008 Vitamin D receptor variants and breast cancer risk in the Polish population.
Breast Cancer Res. Treat. Jun 29 [Epub ahead of print].
-
Gaudet MM, Gammon MD, Bensen JT, Sagiv SK, Shantakumar S, Teitelbaum SL, Eng SM, Neugut AI, Santella RM 2008 Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
Breast Cancer Res. Treat. 108: 93-99.
-
Gennari L 2006 Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
Drugs Today (Barc.) 42: 355-367.
-
Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Mohammad Pezeshki A, Doroudchi M, Dehaghani AS 2004 Cytotoxic T lymphocyte antigen-4 gene in breast cancer.
Breast Cancer Res. Treat. 86: 1-7.
*
-
Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R 2002 A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Clin. Cancer Res. 8: 3820-3823.
*
-
Giercksky KE 2001 COX-2 inhibition and prevention of cancer.
Best Pract. Res. Clin. Gastroenterol. 15: 821-833.
*
-
Girardin F 2006 Membrane transporter proteins: a challenge for CNS drug development.
Dialogues Clin. Neurosci. 8: 311-321.
-
Girvan AC, Teng Y, Casson LK, Thomas SD, Juliger S, Ball MW, Klein JB, Pierce WM Jr, Barve SS, Bates PJ 2006 AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin.
Mol. Cancer Ther. 5: 1790-1799.
*
-
Gissel T, Rejnmark L, Mosekilde L, Vestergaard P 2008 Intake of vitamin D and risk of breast cancer - a meta-analysis.
J. Steroid Biochem. Mol. Biol. 111: 195-199.
-
Glinsky GV 2008 An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway.
Cell Cycle Aug 30 [Epub ahead of print].
*
-
Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR 2004 Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
Int. J. Cancer 112: 754-759.
*
-
Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, Kosarin K, Olsh A, Bergeron J, Ellis NA, Klein RJ, Clark AG, Norton L, Dean M, Boyd J, Offit K 2008 Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
Proc. Natl. Acad. Sci. U.S.A. 105: 4340-4345.
*
-
Golembesky AK, Gammon MD, North KE, Bensen JT, Schroeder JC, Teitelbaum SL, Neugut AI, Santella RM 2008 Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study.
Carcinogenesis Jun 26 [Epub ahead of print].
*
-
Gombart AF, Luong QT, Koeffler HP 2006 Vitamin D compounds: activity against microbes and cancer.
Anticancer Res. 26: 2531-2542.
-
Gong H, Guo P, Zhai Y, Zhou J, Uppal H, Jarzynka MJ, Song W, Cheng S, Xie W 2007 Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor LXR.
Mol. Endocrinol. 21: 1781-1790.
*
-
Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, Manavoglu O 2007 Association of breast cancer and cytokine gene polymorphism in Turkish women.
Saudi Med. J. 28: 1728-1733.
-
Gonzalez-Neira A, Rosa-Rosa JM, Osorio A, Gonzalez E, Southey M, Sinilnikova O, Lynch H, Oldenburg RA, van Asperen CJ, Hoogerbrugge N, Pita G, Devilee P, Goldgar D, Benitez J 2007 Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.
BMC Genomics 8: 299.
*
-
Gonzalez-Zuloeta Ladd AM, Arias Vasquez A, Witteman J, Uitterlinden AG, Coebergh JW, Hofman A, Stricker BH, van Duijn CM 2006 Interleukin 6 G-174 C polymorphism and breast cancer risk.
Eur. J. Epidemiol. 21: 373-376.
*
-
Goudie BM, Burt AD, Boyle P, Macfarlane G, Birnie GG, Mills PR, Gillis CR, MacSween RN, Watkinson G 1985 Breast cancer in women with primary biliary cirrhosis.
Br. Med. J. (Clin. Res. Ed.) 291: 1597-1598.
*
-
Grabinski JL, Smith LS, Chisholm GB, Drengler R, Rodriguez GI, Lang AS, Kalter SP, Garner AM, Fichtel LM, Hollsten J, Pollock BH, Kuhn JG 2006 Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Breast Cancer Res. Treat. 95: 13-16.
-
Granados S, Quiles JL, Gil A, Ramifrez-Tortosa MC 2006 Dietary lipids and cancer.
Nutr. Hosp. 21 Suppl. 2: 42-52, 44-54.
-
Grant SF, Baldassano RN, Hakonarson H 2008 Classification of genetic profiles of Crohn's disease: a focus on the ATG16L1 gene.
Expert Rev. Mol. Diagn. 8: 199-207.
-
Grant WB 2006 Epidemiology of disease risks in relation to vitamin D insufficiency.
Prog. Biophys. Mol. Biol. 92: 65-79.
*
-
Grau de Castro JJ 2005 COX-2 inhibitors in cancer prevention.
Rev. Clin. Esp. 205: 446-456.
-
Greer JB, Whitcomb DC 2007 Role of BRCA1/2 mutations in pancreatic cancer.
Gut 56: 601-605.
*
-
Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B, Gallimore A, Gascoigne NR, Ohashi PS 2004 TCR affinity and negative regulation limit autoimmunity.
Nat. Med. 10: 1234-1239.
*
-
Gupta N, Martin PM, Miyauchi S, Ananth S, Herdman AV, Martindale RG, Podolsky R, Ganapathy V 2006 Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer.
Biochem. Biophys. Res. Commun. 343: 571-577.
*
-
Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J 2005 Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract.
Biochem. Pharmacol. 70: 605-609.
*
-
Hall HT, Wilhelm MT, Saibil SD, Mak TW, Flavell RA, Ohashi PS 2008 RIP2 contributes to Nod signaling but is not essential for T cell proliferation, T helper differentiation or TLR responses.
Eur. J. Immunol. 38: 64-72.
*
-
Hambach L, Vermeij M, Buser A, Aghai Z, van der Kwast T, Goulmy E 2008 Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors.
Blood 112: 1844-1852.
*
-
Hammamieh R, Chakraborty N, Miller SA, Waddy E, Barmada M, Das R, Peel SA, Day AA, Jett M 2007 Differential effects of omega-3 and omega-6 fatty acids on gene expression in breast cancer cells.
Breast Cancer Res. Treat. 101: 7-16.
*
-
Han S, Roman J 2007 Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?
Anticancer Drugs 18: 237-244.
-
Han Y, Sugiyama Y 2006 Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice.
Biol. Pharm. Bull. 29: 1032-1035.
*
-
Hansen TV, Bisgaard ML, Jonson L, Albrechtsen A, Filtenborg-Barnkob B, Eiberg H, Ejlertsen B, Nielsen FC 2008 Novel de novo BRCA2 mutation in a patient with a family history of breast cancer.
BMC Med. Genet. 9: 58.
*
-
Hardman WE 2004 (n-3) Fatty acids and cancer therapy.
J. Nutr. 134: 3427S-3430S.
*
-
Hart CM, Roman J, Reddy R, Sime PJ 2008 PPARgamma: a novel molecular target in lung disease.
J. Investig. Med. 56: 515-517.
-
Hassan F, Islam S, Tumurkhuu G, Naiki Y, Koide N, Mori I, Yoshida T, Yokochi T 2006 Intracellular expression of Toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
BMC Cancer 6: 281.
*
-
Hawkins OE, Vangundy RS, Eckerd AM, Bardet W, Buchli R, Weidanz JA, Hildebrand WH 2008 Identification of breast cancer peptide epitopes presented by HLA-A*0201.
J. Proteome Res. 7: 1445-1457.
*
-
Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson JA 2007 Estrogen receptors: how do they signal and what are their targets.
Physiol. Rev. 87: 905-931.
*
-
Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T 2004 Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients.
Int. J. Cancer 111: 611-616.
*
-
Hemminki K, Forsti A, Lorenzo Bermejo J 2008 Etiologic impact of known cancer susceptibility genes.
Mutat. Res. 658: 42-54.
-
Hemminki K, Li X, Sundquist J, Sundquist K 2008 Cancer risks in ulcerative colitis patients.
Int. J. Cancer 123: 1417-1421.
*
-
Hilakivi-Clarke L, Wang C, Kalil M, Riggins R, Pestell RG 2004 Nutritional modulation of the cell cycle and breast cancer.
Endocr. Relat. Cancer 11: 603-622.
*
-
Hinoda Y, Imai K 1994 Molecular biological analyses of mucin core proteins and their clinical application.
Gan To Kagaku Ryoho 21: 150-156.
-
Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, Sugiyama Y 2005 Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Mol. Pharmacol. 68: 800-807.
*
-
Holick MF 2008 Vitamin D and sunlight: strategies for cancer prevention and other health benefits.
Clin. J. Am. Soc. Nephrol. 3: 1548-1554.
-
Holick MF 2003 Vitamin D: a millenium perspective.
J. Cell Biochem. 88: 296-307.
*
-
Holick MF 2003 Evolution and function of vitamin D.
Recent Results Cancer Res. 164: 3-28.
-
Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sorensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brunner N 2002 Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
Clin. Cancer Res. 8: 156-164.
*
-
Homma S, Sagawa Y, Ito M, Ohno T, Toda G 2006 Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses.
Clin. Exp. Immunol. 144: 41-47.
*
-
Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, Ino Y, Ono M, Hirohashi S 2005 Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer.
Gastroenterology 128: 51-62.
*
-
Hong YS, Lee HJ, You CH, Roh MS, Kwak JY, Lee MJ, Kim JY 2007 DNMT3b 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans.
Biochem. Genet. 45: 155-163.
*
-
Honorat M, Mesnier A, Pietro AD, Lin V, Cohen P, Dumontet C, Payen L 2008 Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells.
Biochem. Biophys. Res. Commun. 375: 308-314.
*
-
Horia E, Watkins BA 2007 Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells.
Carcinogenesis 28: 809-815.
*
-
Howel D, Metcalf JV, Gray J, Newman WL, Jones DE, James OF 1999 Cancer risk in primary biliary cirrhosis: a study in northern England.
Gut 45: 756-760.
*
-
Hu Y, Benya RV, Carroll RE, Diamond AM 2005 Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer.
J. Nutr. 135: 3021S-3024S.
*
-
Huang L, Wang Y, Grimm SW 2006 ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistant protein.
Drug Metab. Dispos. 34: 738-742.
*
-
Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T 2004 NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
J. Clin. Invest. 114: 569-581.
*
-
Hunter DJ, Kraft P 2007 Drinking from the fire hose - statistical issues in genomewide association studies.
N. Engl. J. Med. 357: 436-439.
*
-
Huzarski T, Lener M, Domagala W, Gronwald J, Byrski T, Kurzawski G, Suchy J, Chosia M, Woyton J, Ucinski M, Narod SA, Lubinski J 2005 The 3020insC allele of NOD2 predisposes to early-onset breast cancer.
Breast Cancer Res. Treat. 89: 91-93.
-
Hwang KT, Han W, Bae JY, Hwang SE, Shin HJ, Lee JE, Kim SW, Min HJ, Noh DY 2007 Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer.
J. Korean Med. Sci. 22: S24-S31.
-
Ifergan I, Jansen G, Assaraf YG 2008 The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation: RFC as a double-edged sword in folate homeostasis.
J. Biol. Chem. 283: 20687-20695.
*
-
Ifergan I, Shafran A, Jansen G, Hooijberg JH, Scheffer GL, Assaraf YG 2004 Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: a role for BCRP in cellular folate homeostasis.
J. Biol. Chem. 279: 25527-25534.
*
-
Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW, Selander KS 2007 Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
Prostate 67: 774-781.
-
Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, Hayakawa A, Takeshima Y, Sakaeda T, Matsuo M, Okumura K 2007 Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.
J. Hum. Genet. 52: 166-171.
*
-
Indik S, Gunzburg WH, Salmons B, Rouault F 2005 Mouse mammary tumor virus infects human cells.
Cancer Res. 65: 6651-6659.
*
-
Iobagiu C, Lambert C, Normand M, Genin C 2006 Microsatellite profile in hormonal receptor genes associated with breast cancer.
Breast Cancer Res. Treat. 95: 153-159.
-
Isbilen B, Fraser SP, Djamgoz MB 2006 Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells.
Int. J. Biochem. Cell. Biol. 38: 2173-2182.
*
-
Ivanova A, Ivanov S, Pascal V, Lumsden J, Ward J, Morris N, Tessarolo L, Anderson S, Lerman M 2007 Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1.
J. Pathol. 211: 591-601.
*
-
Jablonska E 1997 Release of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patients.
Cancer Lett. 119: 79-85.
-
Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U 2007 Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Breast Cancer Res. Treat. 104: 299-308.
*
-
James SY, Lin F, Kolluri SK, Dawson MI, Zhang XK 2003 Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
Cancer Res. 63: 3531-3538.
*
-
Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, Bae YS 2006 MLN51 and GM-CSF involvement in fibroblast-like synoviocytes (FLS) proliferation in the pathogenesis of rheumatoid arthritis.
Arthritis Res. Ther. 8: R170.
*
-
Jang JY, Choi Y, Jeon YK, Kim CW 2008 The suppression of adenine nucleotide translocase-2 (ANT2) by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.
Breast Cancer Res. 10: R11.
-
Jansen PL 2006 Genetics of cholestasis.
Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 37-40. *
-
Janvilisri T, Shahi S, Venter H, Balakrishnan L, Van Veen HW 2005 Arginine-482 is not essential for the transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2).
Biochem. J. 385: 419-426.
*
-
Jarrar MH, Baranova A 2007 PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.
J. Cell. Mol. Med. 11: 71-87.
*
-
Javed A, Barnes GL, Pratap J, Antkowiak T, Gerstenfeld LC, van Wijnen AJ, Stein JL, Lian JB, Stein GS 2005 Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
Proc. Natl. Acad. Sci. U.S.A. 102: 1454-1459.
*
-
Jiang Y, Tong D, Lou G, Zhang Y, Geng J 2008 Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Pathobiology 75: 244-251.
-
Jin J, Sun H, Wei H, Liu G 2007 The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
Invest. New Drugs 25: 95-105.
*
-
Jiskra J, Barkmanova J, Limanova Z, Lanska V, Smutek D, Potlukova E, Antosova M 2007 Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival.
Oncol. Rep. 18: 1603-1611.
-
John EM, Schwartz GG, Koo J, Wang W, Ingles SA 2007 Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population.
Am. J. Epidemiol. 166: 1409-1419.
*
-
Johnson BM, Zhang P, Schuetz JD, Brouwer KL 2006 Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats.
Drug Metab. Dispos. 34: 556-562.
*
-
Jolly CA 2005 Diet manipulation and prevention of aging, cancer and autoimmune disease.
Curr. Opin. Clin. Nutr. Metab. Care 8: 382-387.
-
Jones JS, Gu X, Lynch PM, Rodriguez-Bigas M, Amos CI, Frazier ML 2005 ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
Cancer Causes Control 16: 749-753.
*
-
Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Oude Elferink RP, Rosing H, Beijnen JH, Schinkel AH 2002 The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
Proc. Natl. Acad. Sci. U.S.A. 99: 15649-15654.
*
-
Jonker JW, Merino G, Musters S, van Herwaarden AE, Bolscher E, Wagenaar E, Mesman E, Dale TC, Schinkel AH 2005 The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.
Nat. Med. 11: 127-129.
*
-
Jorgenson E, Witte JS 2007 Genome-wide association studies of cancer.
Future Oncol. 3: 419-427.
-
Jourdan ML, Maheo K, Barascu A, Goupille C, De Latour MP, Bougnoux P, Rio PG 2007 Increased BRCA1 protein in mammary tumours of rats fed marine omega-3 fatty acids.
Oncol. Rep. 17: 713-719.
*
-
Jude S, Roger S, Martel E, Besson P, Richard S, Bougnoux P, Champeroux P, Le Guennec JY 2006 Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers.
Prog. Biophys. Mol. Biol. 90: 299-325.
*
-
Jung HY, Park SH, Yoo YD, Kim JS, Kim YH 2005 CDK2/4 regulate retinoic acid-induced G1 arrest in hepatocellular carcinoma cells.
Hepatol. Res. 31: 143-152.
-
Kakizoe T 2003 Chemoprevention of cancer - focusing on clinical trials.
Jpn. J. Clin. Oncol. 33: 421-442.
*
-
Kalli KR, Krco CJ, Hartmann LC, Goodman K, Maurer MJ, Yu C, Johnson EM, Erskine CL, Disis ML, Wettstein PJ, Fikes JD, Beebe M, Ishioka G, Knutson KL 2008 An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
Cancer Res. 68: 4893-4901.
*
-
Kallianpur AR, Hall LD, Yadav M, Christman BW, Dittus RS, Haines JL, Parl FF, Summar ML 2004 Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer.
Cancer Epidemiol. Biomarkers Prev. 13: 205-212.
*
-
Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, Ebner F, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ulbrich C, Chrobok K, Forster G, Praetorius GM, Meyer P, Rehbock J, Cantor CR, Nelson MR, Braun A 2004 Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus.
Cancer Res. 64: 8906-8910.
*
-
Kankesan J, Vanama R, Yusuf A, Thiessen JJ, Ling V, Rao PM, Rajalakshmi S, Sarma DS 2004 Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats.
Carcinogenesis 25: 425-230.
*
-
Kars MD, Iseri OD, Gunduz U, Ural AU, Arpaci F, Molnar J 2006 Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Anticancer Res. 26: 4559-4568.
-
Kasper LH, Everitt D, Leist TP, Ryan KA, Mascelli MA, Johnson K, Raychaudhuri A, Vollmer T; The Multiple Sclerosis Investigators 2006 A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis.
Curr. Med. Res. Opin. 22: 1671-1678.
-
Kass NE, Medley AM, Natowicz MR, Hull SC, Faden RR, Plantinga L, Gostin LO 2007 Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions.
Am. J. Med. Genet. A. 143: 707-717.
-
Kato Y, Takahara S, Kato S, Kubo Y, Sai Y, Tamai I, Yabuuchi H, Tsuji A 2008 Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Drug Metab. Dispos. 36: 1088-1096.
*
-
Kawaoka T, Oka M, Takashima M, Ueno T, Yamamoto K, Yahara N, Yoshino S, Hazama S 2008 Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Oncol. Rep. 20: 155-163.
-
Kemmis CM, Salvador SM, Smith KM, Welsh J 2006 Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3.
J. Nutr. 136: 887-892.
*
-
Kemmis CM, Welsh J 2008 Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
J. Cell. Biochem. Sep 2 [Epub ahead of print].
-
Kilickap S, Ozdamar Y, Altundag MK, Dizdar O 2008 A case report: zoledronic acid-induced anterior uveitis.
Med. Oncol. 25: 238-240.
-
Kim HT, Kong G, Denardo D, Li Y, Uray I, Pal S, Mohsin S, Hilsenbeck SG, Bissonnette R, Lamph WW, Johnson K, Brown PH 2006 Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Cancer Res. 66: 12009-12018.
*
-
Kim TY, Lee HJ, Hwang KS, Lee M, Kim JW, Bang YJ, Kang GH 2004 Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma.
Lab. Invest. 84: 479-484.
*
-
Kinuya S, Bai J, Shiba K, Yokoyama K, Mori H, Fukuoka M, Watanabe N, Shuke N, Michigishi T, Tonami N 2006 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
Ann. Nucl. Med. 20: 29-34.
-
Kitsiou-Tzeli S, Giannatou E, Spanos I, Nicolaidou P, Fretzayas A, Tzetis M, Lazaris D, Kanavakis E, Tsezou A 2007 Steroid hormones polymorphisms and cholelithiasis in Greek population.
Liver Int. 27: 61-68.
*
-
Kivisto KT, Niemi M 2007 Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
Pharm. Res. 24: 239-247.
*
-
Klaassen CD, Lu H 2008 Xenobiotic transporters: ascribing function from gene knockout and mutation studies.
Toxicol. Sci. 101: 186-196.
*
-
Klaassen CD, Slitt AL 2005 Regulation of hepatic transporters by xenobiotic receptors.
Curr. Drug Metab. 6: 309-328.
-
Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M 2001 Familial pancreatic cancer.
Cancer J. 7: 266-273.
-
Knapp P, Jarzabek K, Blachnio A, Zbroch T 2006 The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis.
Ginekol. Pol. 77: 643-651.
-
Ko KH, Kim NK, Yim DJ, Hong SP, Park PW, Rim KS, Kim S, Hwang SG 2006 Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
Anticancer Res. 26: 4229-4233.
-
Kock K, Grube M, Jedlitschky G, Oevermann L, Siegmund W, Ritter CA, Kroemer HK 2007 Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy.
Clin. Pharmacokinet. 46: 449-470.
-
Kodama M, Kodama T 2006 Four problems with the clinical control of interstitial pneumonia, or chronic fatigue syndrome, using the megadose vitamin C infusion system with dehydroepiandrosterone-cortisol annex.
In Vivo 20: 285-291.
-
Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, Von Knebel Doeberitz M 2004 WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.
Int. J. Cancer 109: 385-392.
*
-
Kogai T, Ohashi E, Jacobs MS, Sajid-Crockett S, Fisher ML, Kanamoto Y, Brent GA 2008 Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is meditated by the IGF1/PI3 kinase and p38 MAP kinase signaling pathways.
J. Clin. Endocrinol. Metab. 93: 1884-1892.
*
-
Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, Das BC, Bharadwaj M 2008 Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.
Breast Cancer Res. Treat. Apr 14 [Epub ahead of print].
-
Kokowski K, Harnack U, Dorn DC, Pecher G 2008 Quantification of the CD8+ T cell response against a mucin epitope in patients with breast cancer.
Arch. Immunol. Ther. Exp. (Warsz.) 56: 141-145.
-
Kollara A, Brown TJ 2006 Functional interaction of nuclear receptor coactivator 4 with aryl hydrocarbon receptor.
Biochem. Biophys. Res. Commun. 346: 526-534.
*
-
Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW 1999 Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Am. J. Gastroenterol. 94: 3248-3253.
*
-
Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA 2007 The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Cancer Epidemiol. Biomarkers Prev. 16: 912-916.
*
-
Kovacs E 2001 Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
Biomed. Pharmacother. 55: 391-396.
-
Krathen RA, Berthelot CN, Hsu S 2006 Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patients.
J. Drugs Dermatol. 5: 251-254.
-
Krause R, Matulla-Nolte B, Essers M, Brown A, Hopfenmuller W 2006 UV radiation and cancer prevention: what is the evidence?
Anticancer Res. 26: 2723-2727.
-
Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Koppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H 2004 The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Clin. Cancer Res. 10: 3518-3520.
*
-
Krokan HE, Kavli B, Slupphaug G 2004 Novel aspects of macromolecular repair and relationship to human disease.
J. Mol. Med. 82: 280-297.
-
Kronborg O 2000 Screening for early colorectal cancer.
World J. Surg. 24: 1069-1074.
*
-
Krust A, Kastner P, Petkovich M, Zelent A, Chambon P 1989 A third human retinoic acid receptor, hRAR-gamma.
Proc. Natl. Acad. Sci. U.S.A. 86: 5310-5314.
*
-
Kuijpens JL, Nyklictek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW 2005 Hypothyroidism might be related to breast cancer in post-menopausal women.
Thyroid 15: 1253-1259.
-
Kuriki K, Hirose K, Wakai K, Matsuo K, Ito H, Suzuki T, Hiraki A, Saito T, Iwata H, Tatematsu M, Tajima K 2007 Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese.
Int. J. Cancer 121: 377-385.
*
-
Kusuhara H, Sugiyama Y 2005 Active efflux across the blood-brain barrier: role of the solute carrier family.
Neurorx. 2: 73-85.
-
Kutuzova GD, Deluca HF 2007 1,25-Dihydroxyvitamin D(3) regulates genes responsible for detoxification in intestine.
Toxicol. Appl. Pharmacol. 218: 37-44.
*
-
Kvistborg P, Hadrup SR, Svane IM, Andersen MH, Straten PT 2008 Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients.
Hum. Immunol. 69: 266-272.
-
La Guardia M, Giammanco S, Di Majo D, Tabacchi G, Tripoli E, Giammanco M 2005 Omega 3 fatty acids: biological activity and effects on human health.
Panminerva Med. 47: 245-257.
-
Laitman Y, Kaufman B, Lahad EL, Papa MZ, Friedman E 2007 Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Isr. Med. Assoc. J. 9: 791-796.
-
Lal S, Wong ZW, Jada SR, Xiang X, Chen Shu X, Ang PC, Figg WD, Lee EJ, Chowbay B 2007 Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.
Pharmacogenomics 8: 567-575.
-
Lal S, Wong ZW, Sandanaraj E, Xiang X, Ang PC, Lee EJ, Chowbay B 2008 Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients.
Cancer Sci. 99: 816-823.
*
-
Lalloo AK, Luo FR, Guo A, Paranjpe P, Lee SH, Vyas V, Rubin E, Sinko PJ 2004 Membrane transport of camptothecin is facilitated by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
BMC Med. 2: 16.
*
-
Lasker JN, Sogolow ED, Sharim RR 2005 The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist.
J. Med. Internet Res. 7: e10.
-
Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S 2006 RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Cancer Res. 66: 6512-6520.
*
-
Lechmann M, Shuman N, Wakeham A, Mak TW 2008 The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo.
Proc. Natl. Acad. Sci. U.S.A. 105: 11887-11892.
*
-
Lecomte J, Flament S, Salamone S, Boisbrun M, Mazerbourg S, Chapleur Y, Grillier-Vuissoz I 2008 Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Breast Cancer Res. Treat. Jan 20 [Epub ahead of print].
-
Lee H, Kong SW, Park PJ 2008 Integrative analysis reveals the direct and indirect interactions between DNA copy number aberrations and gene expression changes.
Bioinformatics 24: 889-896.
*
-
Lee J, Safe S 2007 Coactivation of estrogen receptor alpha (ERalpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150).
Arch. Biochem. Biophys. 461: 200-210.
*
-
Lee JW, Jeong EG, Lee SH, Yoo NJ, Lee SH 2007 Somatic mutations of BECN1, an autophagy-related gene, in human cancers.
APMIS 115: 750-756.
*
-
Lee MO, Liu Y, Zhang XK 1995 A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene.
Mol. Cell. Biol. 15: 4194-4207.
*
-
Lee SA, Fowke JH, Lu W, Ye C, Zheng Y, Cai Q, Gu K, Gao YT, Shu XO, Zheng W 2008 Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk.
Am. J. Clin. Nutr. 87: 753-760.
*
-
Lee SS, Jeong HE, Lee JM, Jung HJ, Jang JE, Kim EY, Lee SJ, Shin JG 2007 Identification and functional assessment of BCRP polymorphisms in a Korean population.
Drug Metab. Dispos. 35: 623-632.
*
-
Lei H, Zaloudik J, Vorechovsky I 2002 Lack of association of the -1171 (5A) allele of the MMP3 promoter with breast cancer.
Clin. Chem. 48: 798-799.
*
-
Lemos C, Jansen G, Peters GJ 2008 Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors.
Br. J. Cancer 98: 857-862.
*
-
Lepper ER, Nooter K, Verweij J, Acharya MR, Figg WD, Sparreboom A 2005 Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
Pharmacogenomics 6: 115-138.
-
Leslie EM, Deeley RG, Cole SP 2005 Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Toxicol. Appl. Pharmacol. 204: 216-237.
*
-
Leung KC, Brce J, Doyle N, Lee HJ, Leong GM, Sjogren K, Ho KK 2007 Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Endocrinology 148: 2417-2423.
*
-
Lewis NR, Logan RF, Hubbard RB, West J 2008 No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study.
Aliment. Pharmacol. Ther. 27: 1140-1147.
*
-
Lewis SJ, Harbord RM, Harris R, Smith GD 2006 Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
J. Natl. Cancer Inst. 98: 1607-1622.
*
-
Li G, Chen X, Wang Q, Xu Z, Zhang W, Ye L 2007 The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
J. Huazhong Univ. Sci. Technolog. Med. Sci. 27: 173-175.
-
Li H, Fu ZK, Wang LH, Li DL, Wu N, Zhang J, Li DJ 2008 Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms with susceptibility to breast cancer.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24: 282-284.
-
Li Y, Zhang Y, Hill J, Kim HT, Shen Q, Bissonnette RP, Lamph WW, Brown PH 2008 The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Br. J. Cancer 98: 1380-1388.
*
-
Liede A, Karlan BY, Narod SA 2004 Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
J. Clin. Oncol. 22: 735-742.
-
Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J 2007 Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer.
J. Clin. Oncol. 25: 3837-3845.
-
Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV 2007 Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Mol. Cell. Biochem. 296: 85-95.
*
-
Lin AE, Mak TW 2007 The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells.
Curr. Opin. Immunol. 19: 665-673.
-
Lipozencic J, Marinovic B 2007 What should be used as tools in women at risk of autimmune disease?
Acta Dermatovenerol. Croat. 15: 45.
-
Lipworth L, Tarone RE, McLaughlin JK 2004 Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence.
Ann. Plast. Surg. 52: 598-601.
-
Liscovitch M, Lavie Y 2002 Cancer multidrug resistance: a review of recent drug discovery research.
IDrugs 5: 1-7. *
-
Litovkin KV, Domenyuk VP, Bubnov VV, Zaporozhan VN 2007 Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Exp. Oncol. 29: 295-398.
-
Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG 2001 Identification of a proviral structure in human breast cancer.
Cancer Res. 61: 1754-1759.
*
-
Liu Y, Liu H, Han B, Zhang JT 2006 Identification of 14-3-3{sigma} as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Cancer Res. 66: 3248-3255.
*
-
Liu YE, Pu W, Wang J, Kang JX, Shi YE 2007 Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids.
FEBS J. 274: 3351-3362.
*
-
Lo SH, Chernoff H, Cong L, Ding Y, Zheng T 2008 Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer.
Proc. Natl. Acad. Sci. U.S.A. 105: 12387-12392.
*
-
Loland BF, Baerug AB, Nylander G 2007 Human milk, immune responses and health effects.
Tidsskr. Nor. Laegeforen. 127: 2395-2398.
-
Loof L, Adami HO, Sparen P, Danielsson A, Eriksson LS, Hultcrantz R, Lindgren S, Olsson R, Prytz H, Ryden BO, et al 1994 Cancer risk in primary biliary cirrhosis: a population-based study from Sweden.
Hepatology 20: 101-104.
-
Lortholary A, Cary-Ten Have Dallinga M, El Kouri C, Morineau N, Ramee JF 2007 Paclitaxel-induced lupus.
Presse. Med. 36: 1207-1208.
-
Lotti TM, Comacchi C, Ghersetich I 1999 Cutaneous necrotizing vasculitis. Relation to systemic disease.
Adv. Exp. Med. Biol. 455: 115-125.
-
Lu S, Tran TA, Jones DM, Meyer DR, Ross JS, Fisher HA, Carlson JA 2008 Localized lymphedema (elephantiasis): a case series and review of the literature.
J. Cutan. Pathol. Jun 17 [Epub ahead of print].
-
Lukaszewicz M, Mroczko B, Szmitkowski M 2007 Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease.
Pol. Arch. Med. Wewn. 117: 247-251.
-
Lv H, He Z, Liu X, Yuan J, Yu Y, Chen Z 2007 Reversal of BCRP-mediated multidrug resistance by stable expression of small interfering RNAs.
J. Cell. Biochem. 102: 75-81.
*
-
Lye E, Dhanji S, Calzascia T, Elford AR, Ohashi PS 2008 IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
Eur. J. Immunol. 38: 870-876.
-
Lynch HT, Deters CA, Lynch JF, Brand RE 2004 Familial pancreatic carcinoma in Jews.
Fam. Cancer 3: 233-240.
*
-
Lynch HT, Fusaro RM, Lynch JF, Brand R 2008 Pancreatic cancer and the FAMMM syndrome.
Fam. Cancer 7: 103-112.
*
-
Lynch HT, Rubinstein WS, Locker GY 2004 Cancer in Jews: introduction and overview.
Fam. Cancer 3: 177-192.
*
-
Lynch HT, Shaw TG, Lynch JF 2004 Inherited predisposition to cancer: a historical overview.
Am. J. Med. Genet. 129C: 5-22.
*
-
Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, Wang L, Eckloff BW, Schaid D, Wieben ED, Adjei AA, Weinshilboum RM 2005 Human aromatase: gene resequencing and functional genomics.
Cancer Res. 65: 11071-11082.
*
-
Ma DW, Ngo V, Huot PS, Kang JX 2006 n-3 Polyunsaturated fatty acids endogenously synthesized in fat-1 mice are enriched in the mammary gland.
Lipids 41: 35-39.
-
MacIntyre CR, McIntyre PB 2001 MMR, autism and inflammatory bowel disease: responding to patient concerns using an evidence-based framework.
Med. J. Aust. 175: 127-128.
-
MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland R, Morton SC 2006 Effects of omega-3 fatty acids on cancer risk: a systematic review.
JAMA 295: 403-415.
*
-
Maheo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P, Gore J 2005 Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
Free Radic. Biol. Med. 39: 742-751.
-
Malik FA, Ashraf S, Kayani MA, Jiang WG, Baloch IA, Sadiq R, Mir A, Ansar M 2008 Contribution of BRCA1 germline mutation in patients with sporadic breast cancer.
Int. Semin. Surg. Oncol. 5: 21.
-
Mant C, Gillett C, D'Arrigo C, Cason J 2004 Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies.
Virology 318: 393-404.
*
-
Mant C, Hodgson S, Hobday R, D'Arrigo C, Cason J 2004 A viral aetiology for breast cancer: time to re-examine the postulate.
Intervirology 47: 2-13.
-
Mao Q, Unadkat JD 2005 Role of the breast cancer resistance protein (ABCG2) in drug transport.
AAPS J. 7: E118-E133.
-
Marin JJ, Macias RI, Briz O, Perez MJ, Serrano MA 2005 Molecular bases of the excretion of fetal bile acids and pigments through the fetal liver-placenta-maternal liver pathway.
Ann. Hepatol. 4: 70-76.
-
Marquez-Rosado L, Trejo-Solis MC, Garcia-Cuellar CM, Villa-Trevino S 2005 Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
J. Hepatol. 43: 653-660.
*
-
Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM 2004 Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis.
Am. J. Gastroenterol. 99: 2348-2355.
*
-
Matsson P, Englund G, Ahlin G, Bergstrom CA, Norinder U, Artursson P 2007 A global drug inhibition pattern for the human ABC transporter BCRP (ABCG2).
J. Pharmacol. Exp. Ther. 323: 19-30.
*
-
Matsushima S, Maeda K, Hayashi H, Debori Y, Schinkel AH, Schuetz JD, Kusuhara H, Sugiyama Y 2008 Involvement of multiple efflux transporters in hepatic disposition of fexofenadine.
Mol. Pharmacol. 73: 1474-1483.
*
-
Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y 2005 Identification of the hepatic efflux transporters of organic anions using double transfected MDCKII cells expressing human OATP1B1/MRP2, OATP1B1/MDR1 and OATP1B1/BCRP.
J. Pharmacol. Exp. Ther. 314: 1059-1067.
*
-
Mazokopakis EE, Papadakis JA, Kofteridis DP 2007 Unusual causes of intrahepatic cholestatic liver disease.
World J. Gastroenterol. 13: 1879-1882.
-
Meier-Abt PJ 2003 Transport and metabolic functions.
Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 21-22. October 20 - 21. *
-
Menendez JA, Vazquez-Martin A, Ropero S, Colomer R, Lupu R 2006 HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated. Fatty acid alpha-linolenic acid (ALA; 18:3n-3) in breast cancer cells: the fat features of the Mediterranean diet as an anti-HER2 cocktail.
Clin. Transl. Oncol. 8: 812-820.
-
Merlin JL, Gautier H, Barberi-Heyob M, Teiten MH, Guillemin F 2003 The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells.
Int. J. Oncol. 22: 733-739.
*
-
Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS 2006 Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Mol. Cancer Res. 4: 437-447.
*
-
Miki Y, Suzuki T, Kitada K, Yabuki N, Shibuya R, Moriya T, Ishida T, Ohuchi N, Blumberg B, Sasano H 2006 Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma.
Cancer Res. 66: 535-542.
*
-
Min G 2006 Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
Ann. N. Y. Acad. Sci. 1091: 244-257.
*
-
Mishra S, Saleh A, Espino PS, Davie JR, Murphy LJ 2006 Phosphorylation of histones by tissue transglutaminase.
J. Biol. Chem. 281: 5532-5538.
*
-
Moan J, Porojnicu AC 2006 The photobiology of vitamin D, a topic of renewed focus.
Tidsskr. Nor. Laegeforen 126: 1048-1052.
-
Moffit JS, Aleksunes LM, Maher JM, Scheffer GL, Klaassen CD, Manautou J 2006 Induction of hepatic transporters Mrp3 and Mrp4 by clofibrate is regulated by PPARalpha.
J. Pharmacol. Exp. Ther. 317: 537-545.
*
-
Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS 2008 Anti-tumor necrosis factor therapy in patients with refractory Takayasu's arteritis: long-term follow-up.
Ann. Rheum. Dis. Aug 3 [Epub ahead of print].
-
Moon YJ, Wang X, Morris ME 2006 Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
Toxicol. In Vitro 20: 187-210.
-
Mooney CJ, Dunphy EJ, Stone B, McNeel DG 2006 Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis.
Int. J. Urol. 13: 211-217.
-
Moorman PG, Grubber JM, Millikan RC, Newman B 2003 Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast.
Cancer Causes Control 14: 915-922.
*
-
Motsinger AA, Ritchie MD 2006 Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies.
Hum. Genomics 2: 318-328.
-
Mueller S, Dubal DB, Josephson SA 2008 A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody.
Nat. Clin. Pract. Neurol. 4: 284-288.
-
Murad H, Collet P, Huin-Schohn C, Al-Makdissy N, Kerjan G, Chedotal A, Donner M, Devignes MD, Becuwe P, Schohn H, Domenjoud L, Dauca M 2006 Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells.
Int. J. Oncol. 28: 977-984.
*
-
Muradrasoli S, Forsman A, Hu L, Blikstad V, Blomberg J 2006 Development of real-time PCRs for detection and quantitation of human MMTV-like (HML) sequences HML expression in human tissues.
J. Virol. Methods 136: 83-92.
-
Murakami T, Takano M 2008 Intestinal efflux transporters and drug absorption.
Expert Opin. Drug Metab. Toxicol. 4: 923-939.
-
Nagaoka R, Iwasaki T, Rokutanda N, Takeshita A, Koibuchi Y, Horiguchi J, Shimokawa N, Iino Y, Morishita Y, Koibuchi N 2006 Tamoxifen activates CYP3A4 and MDR1 genes through steroid and xenobiotic receptor in breast cancer cells.
Endocrine 30: 261-268.
-
Nagpal S, Na S, Rathnachalam R 2005 Non-calcemic actions of vitamin D receptor ligands.
Endocr. Rev. 26: 662-687.
*
-
Nair S, Mason A, Eason J, Loss G, Perrillo RP 2002 Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Hepatology 36: 150-155.
*
-
Nakajima M, Komagata S, Fujiki Y, Kanada Y, Ebi H, Itoh K, Mukai H, Yokoi T, Minami H 2007 Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
Pharmacogenet. Genomics 17: 431-445.
-
Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM 2008 Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.
Cancer Res. 68: 3915-3923.
*
-
Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM 2008 An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.
Cancer Res. 68: 3835-3843.
*
-
Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters CM 2008 Dexamethasone increases expression and activity of multi-drug resistance transporters at the rat blood-brain barrier.
Am. J. Physiol. Cell Physiol. 295: C440-C450.
*
-
Narayanan BA 2006 Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets.
Curr. Cancer Drug Targets 6: 711-727.
-
Nazareno J, Taves D, Preiksaitis HG 2006 Metastatic breast cancer to the gastrointestinal tract: a case series and review of the literature.
World J. Gastroenterol. 12: 6219-6224.
*
-
Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA; The Wellcome Trust Case Control Consortium 2007 Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.
Nature 450: 887-892.
*
-
Neurath MF 2007 IL-23: a master regulator in Crohn disease.
Nat. Med. 13: 26-28.
*
-
Nicolau M, Tibshirani R, Borresen-Dale AL, Jeffrey SS 2007 Disease-specific genomic analysis: identifying the signature of pathologic biology.
Bioinformatics 23: 957-965.
*
-
Nishino R, Honda M, Yamashita T, Takatori H, Minato H, Zen Y, Sasaki M, Takamura H, Horimoto K, Ohta T, Nakanuma Y, Kaneko S 2008 Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
J. Hepatol. 49: 207-216.
-
Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lonning PE, Borresen-Dale AL, Kristensen VN 2007 ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Pharmacogenet. Genomics 17: 127-136.
-
Nurnberg B, Schadendorf D, Gartner B, Pfohler C, Herrmann W, Tilgen W, Reichrath J 2008 Progression of malignant melanoma is associated with reduced 25-hydroxyvitamin D serum levels.
Exp. Dermatol. 17: 627.
-
Oba M, Sasaki M, Ii T, Hoso M, Ajisaka H, Matsuki N, Miwa K 2008 A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma.
Breast Cancer Sep 4 [Epub ahead of print].
-
Odze RD 2005 Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.
Am. J. Gastroenterol. 100: 1853-1867.
*
-
Ogawa Y, Murata Y, Saibara T, Nishioka A, Kariya S, Yoshida S 2003 Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.
Oncol. Rep. 10: 1473-1478.
-
Ohashi PS, Woodgett JR 2005 Modulating autoimmunity: pick your PI3 kinase.
Nat. Med. 11: 924-925.
*
-
Ohashi PS, Yeh WC 2006 Supressing the supressors.
Nat. Med. 12: 1000-1002.
*
-
Ohnishi T, Ogawa Y, Saibara T, Nishioka A, Kariya S, Fukumoto M, Onishi S, Yoshida S 2005 CYP17 polymorphism and tamoxifen-induced hepatic steatosis.
Hepatol. Res. 33: 178-180.
-
Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H 2004 Retinoids in cancer chemoprevention.
Curr. Cancer Drug Targets 4: 285-298.
-
Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM 2005 Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales.
Transplantation 80: 759-764.
-
Oshima H, Kon J, Ooe H, Hirata K, Mitaka T 2008 Functional expression of organic anion transporters in hepatic organoids reconstructed by rat small hepatocytes.
J. Cell. Biochem. 104: 68-81.
*
-
Osipo C, Golde TE, Osborne BA, Miele LA 2008 Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.
Lab. Invest. 88: 11-17.
*
-
Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W 2005 Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
J. Pathol. 207: 185-198.
*
-
Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE 2005 Noninvasive testing for colorectal cancer: a review
Am. J. Gastroenterol. 100: 1393-1403.
*
-
Paik J, Blaner WS, Swisshelm K 2005 cis-Retinol dehydrogenase: 9-cis-retinol metabolism and its effect on proliferation of human MCF7 breast cancer cells.
Exp. Cell Res. 303: 183-196.
*
-
Paradis V, Bedossa P 2007 In the new area of noninvasive markers of hepatocellular carcinoma.
J. Hepatol. 46: 9-11.
*
-
Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY 2007 NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.
Nat. Med. 13: 62-69.
*
-
Pavan B, Biondi C, Dalpiaz A 2006 Nuclear retinoic acid receptor beta as a tool in chemoprevention trials.
Curr. Med. Chem. 13: 3553-3563.
-
Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH 2005 Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine.
J. Pharmacol. Exp. Ther. 312: 144-152.
*
-
Pearce EG, Laxton RC, Pereira AC, Ye S 2007 Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells.
Mol. Cancer Res. 5: 221-227.
*
-
Peng C, Zhou RL, Shao GZ, Rui JA, Wang SB, Lin M, Zhang S, Gao ZF 2005 Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.
World J. Gastroenterol. 11: 2704-2708.
*
-
Peng X, Maruo T, Cao Y, Punj V, Mehta R, Das Gupta TK, Christov K 2004 A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Cancer Res. 64: 8911-8918.
*
-
Peng X, Mehta R, Wang S, Chellappan S, Mehta RG 2006 Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.
Cancer Res. 66: 7361-7369.
*
-
Pereira MA, Segura ME, Santos AM, Casulari LA 2007 Regression of the fibrous disease of the breast in a non-diabetic woman after pregnancy and breastfeeding.
Arq. Bras. Endocrinol. Metabol. 51: 1539-1543.
-
Perez SA, Karamouzis MV, Skarlos DV, Ardavanis A, Sotiriadou NN, Iliopoulou EG, Salagianni ML, Orphanos G, Baxevanis CN, Rigatos G, Papamichail M 2007 CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients.
Clin. Cancer Res. 13: 2714-2721.
*
-
Perez-Fernandez R, Seoane S, Garcia-Caballero T, Segura C, Macia M 2007 Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Curr. Med. Chem. 14: 3051-3058.
-
Petraccia L, Onori P, Sferra R, Lucchetta MC, Liberati G, Grassi M, Gaudio E 2003 MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications.
Clin. Ter. 154: 325-335.
-
Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA; SEARCH Investigators 2007 Association between common variation in 120 candidate genes and breast cancer risk.
PLoS Genet. 3: e42.
*
-
Piscaglia AC, Shupe TD, Petersen BE, Gasbarrini A 2007 Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth...
Curr. Cancer Drug Targets 7: 582-590.
-
Piscaglia F, Sagrini E 2008 Malignancies in primary biliary cirrhosis.
Eur. J. Gastroenterol. Hepatol. 20: 1-4.
-
Pitarch G, Sanchez-Carazo JL, Mahiques L, Perez-Ferriols MA, Fortea JM 2007 Treatment of psoriasis with adalimumab.
Clin. Exp. Dermatol. 32: 18-22.
*
-
Plasschaert SL, Van Der Kolk DM, De Bont ES, Vellenga E, Kamps WA, De Vries EG 2004 Breast cancer resistance protein (BCRP) in acute leukemia.
Leuk. Lymphoma 45: 649-654.
-
Poola I, Dewitty RL, Marshalleck JJ, Bhatnagar R, Abraham J, Leffall LD 2005 Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.
Nat. Med. 11: 481-483.
*
-
Popov VM, Wang C, Shirley LA, Rosenberg A, Li S, Nevalainen M, Fu M, Pestell RG 2007 The functional significance of nuclear receptor acetylation.
Steroids 72: 221-230.
-
Porojnicu AC, Robsahm TE, Dahlback A, Berg JP, Christiani D, Bruland OS, Moan J 2007 Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role?
Lung Cancer 55: 263-270.
-
Poupon R 1991 Primary biliary cirrhosis.
Schweiz. Med. Wochenschr. 121: 727-732.
-
Poupon R, Poupon RE 2004 Retrovirus infection as a trigger for primary biliary cirrhosis?
Lancet 363: 260-261.
*
-
Powell N, Dudley E, Morishita M, Bogdanova T, Tronko M, Thomas G 2004 Single nucleotide polymorphism analysis in the human phosphatase PTPrj gene using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Rapid Commun. Mass Spectrom. 18: 2249-2254.
*
-
Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL, Stein GS 2006 Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
Cancer Metastasis Rev. 25: 589-600.
*
-
Prince MM, Hein MJ, Ruder AM, Waters MA, Laber PA, Whelan EA 2006 Update: cohort mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the manufacture of electrical capacitors, 1940-1998.
Environ. Health 5: 13.
*
-
Prinz-Langenohl R, Fohr I, Pietrzik K 2001 Beneficial role for folate in the prevention of colorectal and breast cancer.
Eur. J. Nutr. 40: 98-105.
*
-
Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, et al 2007 Network modeling links breast cancer susceptibility and centrosome dysfunction.
Nat. Genet. 39: 1338-1349.
*
-
Rahman N, Scott RH 2007 Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players.
Hum. Mol. Genet. 16 Spec. No. 1: R60-R66.
-
Rahn JJ, Shen Q, Mah BK, Hugh JC 2004 MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1.
J. Biol. Chem. 279: 29386-29390.
*
-
Raju U, Levitz M, Javitt NB 1990 Bile acids in human breast cyst fluid: the identification of lithocholic acid.
J. Clin. Endocrinol. Metab. 70: 1030-1034.
-
Rao PN, Crippin J, Levine E, Hunt J, Baliga S, Balart L, Anthony L, Mulekar M, Raj MH 2006 Elevation of serum riboflavin carrier protein in hepatocellular carcinoma.
Hepatol. Res. 35: 83-87.
-
Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE 2006 Proinflammatory CD4+CD45RBhi lymphocytes promote mammary and intestinal carcinogenesis in ApcMin/+ mice.
Cancer Res. 66: 57-61.
*
-
Reddy SM, Pui JC, Gold LI, Mitnick HJ 2005 Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review.
Semin. Arthritis Rheum. 34: 728-734.
*
-
Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC 2007 Vitamins as hormones.
Horm. Metab. Res. 39: 71-84.
-
Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M 2007 The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Clin. Biochem. 40: 981-985.
*
-
Reszka E, Wasowicz W, Gromadzinska J 2006 Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Br. J. Nutr. 96: 609-619.
*
-
Rex DK 2003 Colorectal cancer surveillance, screening, and colonoscopy.
American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course, October 10 - 15, 2003, Baltimore, Maryland.
-
Riegler G, Caserta L, Castiglione F, Esposito I, Valpiani D, Annese V, Zoli G, Gionchetti P, Viscido A, Sturniolo GC, Rispo A, De Filippo FR, de Leone A, Carratu R; IG-IBD Group 2006 Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.
Dig. Liver Dis. 38: 18-23.
-
| |
